| Management of severe asthma: a European respiratory society/American thoracic society guideline F Holguin, JC Cardet, KF Chung, S Diver, DS Ferreira, A Fitzpatrick, ... European respiratory journal 55 (1), 2020 | 608 | 2020 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, HJC McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 584 | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 440 | 2021 |
| Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized … GD Perkins, C Ji, BA Connolly, K Couper, R Lall, JK Baillie, JM Bradley, ... Jama 327 (6), 546-558, 2022 | 361 | 2022 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 358 | 2022 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 282 | 2022 |
| Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind … S Diver, L Khalfaoui, C Emson, SE Wenzel, A Menzies-Gow, ME Wechsler, ... The Lancet Respiratory Medicine 9 (11), 1299-1312, 2021 | 251 | 2021 |
| Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles MA Ghebre, PH Pang, S Diver, D Desai, M Bafadhel, K Haldar, T Kebadze, ... Journal of Allergy and Clinical Immunology 141 (6), 2027-2036. e12, 2018 | 156 | 2018 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial E Abaleke, M Abbas, S Abbasi, A Abbott, A Abdelaziz, S Abdelbadiee, ... The Lancet 397 (10274), 605-612, 2021 | 130 | 2021 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 129 | 2021 |
| ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions A Bourdin, L Bjermer, C Brightling, GG Brusselle, P Chanez, KF Chung, ... European respiratory journal 54 (3), 2019 | 128 | 2019 |
| SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ... EBioMedicine 87, 2023 | 92 | 2023 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 86 | 2022 |
| The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study PJ McDowell, S Diver, F Yang, C Borg, J Busby, V Brown, R Shrimanker, ... The Lancet Respiratory Medicine 9 (10), 1174-1184, 2021 | 74 | 2021 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10320), 143-151, 2022 | 58 | 2022 |
| Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD S Winslow, L Odqvist, S Diver, R Riise, S Abdillahi, C Wingren, ... European Respiratory Journal 58 (4), 2021 | 48 | 2021 |
| Cough and eosinophilia S Diver, RJ Russell, CE Brightling The Journal of Allergy and Clinical Immunology: In Practice 7 (6), 1740-1747, 2019 | 47 | 2019 |
| Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma L Chachi, S Diver, H Kaul, MC Rebelatto, A Boutrin, P Nisa, P Newbold, ... European Respiratory Journal 54 (5), 2019 | 46 | 2019 |
| Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus‐predominant subgroup S Diver, M Richardson, K Haldar, MA Ghebre, MY Ramsheh, M Bafadhel, ... Allergy 75 (4), 808-817, 2020 | 45 | 2020 |
| New and emerging drug treatments for severe asthma S Diver, RJ Russell, CE Brightling Clinical & Experimental Allergy 48 (3), 241-252, 2018 | 42 | 2018 |
